Product NDC: | 63739-450 |
Proprietary Name: | buPROPion Hydrochloride |
Non Proprietary Name: | buPROPion Hydrochloride |
Active Ingredient(s): | 150 mg/1 & nbsp; buPROPion Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63739-450 |
Labeler Name: | McKesson Packaging Services Business Unit of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077285 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110221 |
Package NDC: | 63739-450-10 |
Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-450-10) > 10 TABLET in 1 BLISTER PACK |
NDC Code | 63739-450-10 |
Proprietary Name | buPROPion Hydrochloride |
Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-450-10) > 10 TABLET in 1 BLISTER PACK |
Product NDC | 63739-450 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | buPROPion Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110221 |
Marketing Category Name | ANDA |
Labeler Name | McKesson Packaging Services Business Unit of McKesson Corporation |
Substance Name | BUPROPION HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |